Table. Neutralizing antibody (NAb) titers against Andes virus (AND) and Sin Nombre virus (SNV) in survivors of hantavirus infection from Chile and the United States.
Patient | Origin | Years after infection | AND NAb titer | SNV NAb titer |
---|---|---|---|---|
1 | Chile | 3 | >1:1,600 | 1:100 |
2 | Chile | 4 | 1:400 | <1:100 |
3 | Chile | 7 | >1:1,600 | <1:100 |
4 | Chile | 0.7 | 1:400 | <1:100 |
5 | Chile | 4 | 1:400 | <1:100 |
6 | Chile | 1 | 1:400 | <1:100 |
7 | Chile | 4 | 1:800 | 1:100 |
8 | Chile | 3 | 1:200 | <1:100 |
9 | Chile | 4 | >1:1,600 | <1:100 |
10 | Chile | 7 | 1:400 | <1:100 |
11 | Chile | 1 | 1:400 | <1:100 |
12 | USA | 1 | <1:100 | 1:800 |
13 | USA | 3 | <1:100 | 1:400 |
14 | USA | 4 | <1:100 | 1:400 |
15 | USA | 4 | 1:100 | >1:1,600 |
16 | USA | 3 | <1:100 | 1:400 |
17 | USA | 5 | <1:100 | >1:1,600 |
18 | USA | 11 | <1:100 | 1:400 |
19 | USA | 6 | <1:100 | 1:800 |
20 | USA | 4 | <1:100 | >1:1,600 |